MEDIFICE
The computed 12-month bankruptcy probability of MEDIFICE is 3.4% (moderate). The 2024 annual accounts show negative equity (€-15k) and a net result of €1k. Equity is shrinking by ~73.5% per year across the filed fiscal years. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-15k |
| Net result | €1k |
| Active | 5 yrs |
| Board | 1 |
Mixed profile: strong on stability, weaker on profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €41k |
| Net profit | €1k |
| Cash flow | €14k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €1.05M |
| Equity | €-15k |
| Debt | €1.06M |
| of which ≤ 1y | €79k |
| of which > 1y | €979k |
| Working capital | €23k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 1.30 |
| Quick ratio | 1.30 |
| Working capital ratio | 2.2% |
| Solvency | -1.4% |
| Debt / equity | -71.82 |
| Long-term debt ratio | -66.26 |
| Interest coverage | 1.53 |
| Gross margin | - |
| Net margin | - |
| ROA | 0.1% |
| ROE | -8.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.05M |
| Fixed assets | 21/28 | €945k |
| Tangible fixed assets | 22/27 | €943k |
| Financial fixed assets | 28 | €2k |
| Current assets | 29/58 | €102k |
| Amounts receivable within one year | 40/41 | €56k |
| Cash & bank | 54/58 | €45k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.05M |
| Equity | 10/15 | €-15k |
| Contributions / capital | 10/11 | €42k |
| Accumulated profits (losses) | 14 | €-57k |
| Amounts payable | 17/49 | €1.06M |
| Amounts payable after one year | 17 | €979k |
| Amounts payable within one year | 42/48 | €79k |
| Trade debts payable within one year | 44 | €64k |
| Income statement | ||
| Gross operating margin | 9900 | €41k |
| Operating result | 9901 | €28k |
| Financial charges | 65 | €27k |
| Result before taxes | 9903 | €1k |
| Net result for the period | 9904 | €1k |
| Result to be appropriated | 9905 | €1k |
-
Current07-07-2025 → present
Former directors (1)
-
Former- → 20-12-2021
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 29-10-2020 |
| Status | Active |
| Postal code | 1450 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25022B0299/00C000 | Wallonia | 4,423 m² | 1 · 137 m² | 9.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
30-10-2025 Paul RONSE appointed as director
- Paul RONSE, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul RONSE",
"address": null,
"birth_date": null
},
"effective_date": "2025-07-07",
"evidence_quote": "Monsieur Paul RONSE, n\u00E9 le 08 janvier 1996, est pr\u00E9sent et accepte son mandat d\u0027administrateur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0757.632.950",
"name_full": "MEDIFICE",
"legal_form": "SRL"
}
}20-12-2021 BLEECKX Alain-François resigns as director
- BLEECKX Alain-François, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BLEECKX Alain-Fran\u00E7ois",
"address": null,
"birth_date": null
},
"evidence_quote": "Monsieur Bleeckx Alain-Fran\u00E7ois remet sa d\u00E9mission comme administrateur de MEDIFICE, Celle-ci est accept\u00E9e sans r\u00E9serve par Mesdames AUJOULAT et DETIFFE.",
"discharge_granted": false
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0757.632.950",
"name_full": "MEDIFICE",
"legal_form": "SRL"
}
}03-11-2020 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1450 Cortil-Noirmont, Rue du Dessus 60",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1963-11-30",
"name": "BLEECKX Alain-Fran\u00E7ois Ghislain Marie Jacques Pierre Jos\u00E9e",
"niss": null,
"address": "1450 Chastre (Cortil-Noirmont), rue du Dessus, 60"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 14000,
"holder_person_name": "BLEECKX Alain-Fran\u00E7ois Ghislain Marie Jacques Pierre Jos\u00E9e",
"is_subscriber_only": true,
"n_shares_subscribed": 40,
"amount_subscribed_eur": 14000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1988-01-20",
"name": "AUJOULAT Chlo\u00EB L\u00E9a",
"niss": null,
"address": "1457 Walhain (Walhain-Saint-Paul), Grand\u2019Rue 81"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 14000,
"holder_person_name": "AUJOULAT Chlo\u00EB L\u00E9a",
"is_subscriber_only": true,
"n_shares_subscribed": 40,
"amount_subscribed_eur": 14000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1989-01-30",
"name": "DETIFFE Aliz\u00E9e",
"niss": null,
"address": "1050 Ixelles, Rue W\u00E9ry 24 bo\u00EEte 2/e"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 14000,
"holder_person_name": "DETIFFE Aliz\u00E9e",
"is_subscriber_only": true,
"n_shares_subscribed": 40,
"amount_subscribed_eur": 14000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 42000,
"subject_company": {
"kbo": "0757.632.950",
"name_full": "MEDIFICE",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2020-10-23",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | MEDIFICE |